Triple
T2138538
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Lucentis |
E46708
|
entity |
| Predicate | instanceOf |
P0
|
FINISHED |
| Object | anti-VEGF agent |
C7047
|
CONCEPT FINISHED |
How this triple was built (1 step)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
CD
Concept disambiguation
gpt-5-mini-2025-08-07
Target class: anti-VEGF agent Context triple: [Lucentis, instanceOf, anti-VEGF agent]
-
A.
immunosuppressive agent
An immunosuppressive agent is a drug or substance that reduces or inhibits the activity of the immune system to prevent or treat immune-mediated damage, such as in organ transplantation or autoimmune diseases.
-
B.
pegylated interferon beta-1a
Pegylated interferon beta-1a is a long-acting, pegylated form of interferon used as a disease-modifying therapy to reduce relapses and slow progression in patients with relapsing forms of multiple sclerosis.
-
C.
monoclonal antibody
chosen
A monoclonal antibody is a laboratory-produced molecule engineered to bind specifically to a single epitope on an antigen, enabling targeted detection or treatment of diseases.
-
D.
biologic therapy
Biologic therapy is a treatment that uses substances made from living organisms or their derivatives to target specific components of the immune system or disease processes.
-
E.
antisense oligonucleotide
An antisense oligonucleotide is a short, synthetic strand of nucleic acid designed to bind specifically to a target RNA sequence and modulate its function, typically to alter gene expression for therapeutic purposes.
- F. None of above.
Provenance (1 batch)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69a88a174ab48190a5db20c132e5dccf |
completed | March 4, 2026, 7:37 p.m. |
Created at: March 4, 2026, 7:44 p.m.